Navigation Links
Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010
Date:10/20/2010

0%, compared to 4.4% in the prior year. Days sales outstanding were 43 days, unchanged from the beginning of the year. Cash flow from operations was $330 million compared to $374 million for 2009. During the quarter, the company repurchased $324 million of its common shares and made capital expenditures of $47 million.

Year-to-Date PerformanceFor the first nine months of 2010, income from continuing operations was $556 million, or $3.09 per diluted share, compared to $549 million, or $2.91 per diluted share, for the first nine months of 2009. Revenues of $5.5 billion were 1.1% below the prior year level.

Operating income for the first nine months of 2010 was $1.0 billion, or 18.1% of revenues, compared to $1.0 billion, or 18.3% of revenues, for 2009. Cash from operations was $778 million, compared to $637 million in the first nine months of 2009. Cash provided by operations in 2009 was reduced by the net impact of the NID settlement. During the first nine months of 2010, the company repurchased $750 million of its shares and made capital expenditures of $136 million.

Outlook for the Full-Year 2010 UpdatedFull-year 2010 guidance, before potential special items, is:

  • Earnings per diluted share from continuing operations, $3.95 to $4.00;
  • Revenues, approximately 1.5% below the prior year, versus previous expectation of  approximately 1% below the prior year;
  • Operating income, between 17.5% and 18% of revenues;
  • Cash from operations, approximately $1.1 billion; and
  • Capital expenditures, approximately $200 million.

  • Quest Diagnostics will hold its third quarter conference call on October 20, 2010 at 8:30 a.m. Eastern Time. The public may access the conference call through a live audio webcast available on Quest Diagnostics' Investor Relations Internet site at www.QuestDiagnostics.com/investor. The conference call can also be accessed
    '/>"/>

    SOURCE Quest Diagnostics Incorporated
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
    2. VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
    3. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
    4. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
    5. VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor
    6. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
    7. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
    8. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
    9. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
    10. BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack
    11. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/29/2014)... , Sept. 29, 2014 Pharmaceutical Care Management ... today outlined policy solutions that could reduce prescription fraud ... Hill briefing, " Prescription Opioid Abuse: Fighting Back on ... Reform and PCMA. The briefing featured ... prescription drug abuse and fraud. The Centers for Disease ...
    (Date:9/29/2014)... YORK , Sept. 29, 2014 ... Summary GlobalData,s new report, "EU5 Esophagoscopes ... market data on the EU5 Esophagoscopes & Gastroscopes ... US dollars, volume (in units) and average prices ... Video Esophagoscopes, Flexible Non-Video (Fibre) Gastroscopes and Flexible ...
    (Date:9/29/2014)... BEIJING , Sept. 29, 2014  Following US and ... accelerator, the China Food and Drug Administration (CFDA) has ... in the country. According to the International ... people are diagnosed with cancer every year in ... types including lung, gastric, colorectal, liver and esophageal cancers ...
    Breaking Medicine Technology:PCMA: How Congress Can Fight Prescription Drug Fraud and Abuse 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 3Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 2Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 3
    ... DIEGO, Dec. 18 Ambrx Inc. today announced ... with Merck & Co. Inc. to,develop a novel ... Factor 21 (FGF-21) for the treatment of type ... The collaboration utilizes Ambrx,s proprietary protein technology,ReCODE(TM), ...
    ... Epeius Biotechnologies,Corporation announced today that the company ... Rexin-G(R) from the Philippine Bureau of Food ... lead product as a safe,and effective treatment ... as a tumor-targeted anticancer agent, that actively ...
    Cached Medicine Technology:Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc. 2ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer 2ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer 3
    (Date:9/30/2014)... DC (PRWEB) September 30, ... **MEDIA ADVISORY** , From:        Hope ... Barnwell, 910.554.1505, abarnwell(at)hopeforthewarriors(dot)org ... Hope® Celebration , Date:        Thursday, ... Address:    The Army and Navy ...
    (Date:9/30/2014)... Barbara Williamson shares her life story for the ... Life: Love, Sex and Commitment" . As co-founder with ... highly successful and controversial Sandstone Retreat in Malibu, California, ... started what became known as the hub of the ... outrageously popular, with a membership reaching 500 and nearly ...
    (Date:9/30/2014)... 2014 Computer Resources of America, ... based in New York City, has been awarded ... to transform, manage, and support the IT environment ... a leading provider of innovative services that enable ... The contract will cover the four NY-metro ...
    (Date:9/30/2014)... September 30, 2014 Bibliomotion is ... Redefining Leadership for the Complex Social Age by ... 2014). , In the book, the authors apply their leadership ... which to view the conversations, actions, and behaviors that leaders ... world. Click here to read a review of ...
    (Date:9/30/2014)... 2014 RBS Reputation Management is reported to ... Your Name’. , The service name may surprise as ... the service this odd name, a management professional said, “This ... this name. We have named the service ‘Remove Your Name’ ... get rid of all those posts which light their name ...
    Breaking Medicine News(10 mins):Health News:Hope For The Warriors' Got Heart, Give Hope Celebration Media Advisory 2Health News:The Autobiography "An Extraordinary Life: Love, Sex and Commitment" Embraces Healthy Sexual Behavior 2Health News:The Autobiography "An Extraordinary Life: Love, Sex and Commitment" Embraces Healthy Sexual Behavior 3Health News:CRA Awarded Managed Services Contract for Large NYC Nonprofit 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 3Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 4Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 5Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 6Health News:RBS Reputation Management Announces A New Service ‘Remove Your Name’ 2
    ... virus should be monitored for high blood pressure, expert ... Adults with the skin disease shingles appear to be ... the area around the eyes, researchers report. , Previous ... exact frequency and risk for these phenomena are still ...
    ... types of human papillomavirus (HPV), a sexually transmitted virus, ... Current guidelines prioritize HPV vaccination of pre-adolescent girls, which ... but the value of vaccinating boys in the United ... School of Public Health (HSPH) researchers found that if ...
    ... Study finds two-thirds of those with the mysterious illness infected ... About two-thirds of patients with chronic fatigue syndrome sampled in ... , The finding, albeit preliminary, has raised hopes that there ... thus, down the line, treatments for the disease. , "This ...
    ... Reportlinker.com announces that a new market research report ... Reportlinker Adds Germany Wound Care Management Market Analysis ... http://www.reportlinker.com/p0151443/Reportlinker-Adds-Germany-Wound-Care-Management-Market-Analysis-and-Forecasts-to-2015.html , ... Analysis and Forecasts to 2015 report provides key ...
    ... Biomonitoring Study Detects Four Chemicals from EPA,s Recently-Announced Top ... Physicians for Social Responsibility (PSR), American Nurses Association (ANA) ... Chemicals In Health Care," the first investigation of ... , Today,s announcement was made on a national teleconference ...
    ... cause of death worldwide. Our evolutionary struggle with this ... UC Riverside. Population geneticist Leonard Nunney will ... Struggle With Cancer," at 7 p.m., Thursday, Oct. 15, in ... p.m. Seating is open. "Cancer is unlike other diseases," ...
    Cached Medicine News:Health News:Shingles Raises Stroke Risk: Study 2Health News:Shingles Raises Stroke Risk: Study 3Health News:Vaccinating boys against human papillomavirus not cost-effective 2Health News:Vaccinating boys against human papillomavirus not cost-effective 3Health News:Retrovirus May Be at Root of Chronic Fatigue Syndrome 2Health News:Retrovirus May Be at Root of Chronic Fatigue Syndrome 3Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 2Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 3Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 4Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 5Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 6Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 7Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 8Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 9Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 10Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 11Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 12Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 13Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 14Health News:Toxic Chemicals Found in Doctors and Nurses 2Health News:Evolutionary struggle with cancer is focus of public lecture at UC Riverside 2
    Used for vascular access. Supplied sterile in peel-open packages. Intended for one-time use....
    Used for placement of .035 inch (0.89 mm) or .038 inch (0.97 mm) diameter wire guides into the vascular system when a small 24 gage needle stick is desired....
    Used to introduce large devices for vascular intervention....
    Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....
    Medicine Products: